KMT2A and acute lymphoblastic leukemia: The 5-year event-free survival rates of infants with MLL-rearranged acute lymphoid leukemia (ALL) are only 30–40% [5], and the 5-year-event-free survival rates for patients with MLL-rearranged acute myeloid leukemia (AML) are 34–61% [6].